Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing

Parenteral prostanoids are being recommended in pulmonary arterial hypertension (PAH) treatment, but the prognostic relevance of delayed treatment initiation is still debated. This study assessed the impact of the timing of prostacyclin treatment initiation on reducing PVR and achieving a low-risk p...

Descripción completa

Detalles Bibliográficos
Autores principales: Papa, Silvia, Scoccia, Gianmarco, Serino, Giorgia, Adamo, Francesca Ileana, Jabbour, Jean Pierre, Caputo, Annalisa, Boromei, Michela, Filomena, Domenico, Laviola, Domenico, Maggio, Enrico, Manzi, Giovanna, Mihai, Alexandra, Recchioni, Tommaso, Sabusco, Alexandra, Valeri, Livia, Vinciullo, Sara, Vizza, Carmine Dario, Badagliacca, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648828/
https://www.ncbi.nlm.nih.gov/pubmed/37959305
http://dx.doi.org/10.3390/jcm12216840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648828/
https://www.ncbi.nlm.nih.gov/pubmed/37959305
http://dx.doi.org/10.3390/jcm12216840

Ejemplares similares